Not Signed In -
Ovarian Cancer |
|
|
Ovarian cancer is a malignant ovarian neoplasm (an abnormal growth located on the ovaries). Causes Ovarian cancer is the fifth leading cause of cancer death in women, the leading cause of death from gynecologic malignancies and the second most commonly diagnosed gynecologic malignancy [1]. It is idiopathic, meaning that the exact cause is unknown. The disease is more common in industrialized nations, with the exception of Japan. In the United States, females have a 1.4 % to 2.5 % (1 out ...
Wikipedia - [full article]
Ovarian Cancer Clinical Trials
- TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00022347 - Active, not recruiting
ovarian serous cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ...
- Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003322 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ...
- Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission
ClinicalTrials.gov Identifier: NCT00002977 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; stage IV ovarian epithelial cancer; ...
- Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
ClinicalTrials.gov Identifier: NCT00002538 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; stage I ovarian epithelial cancer; ...
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00005612 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00005026 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00017303 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00002568 - Active, not recruiting
ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; ovarian endometrioid adenocarcinoma; ...
- Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00003967 - Active, not recruiting
ovarian serous cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ...
- Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003944 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00002477 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer
- Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00101257 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00003413 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003297 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00028743 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00004166 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003733 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00002717 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003358 - Active, not recruiting
recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; ...
- Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00034151 - Active, not recruiting
Ovarian Cancer
- Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00021385 - Active, not recruiting
recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; stage IV ovarian germ cell tumor; ...
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00041080 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
ClinicalTrials.gov Identifier: NCT00003160 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
- Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects with Relapsed or Refractory Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00113789 - Active, not recruiting
Ovarian Cancer
- National Ovarian Cancer Early Detection Program Screening and Genetic Study
ClinicalTrials.gov Identifier: NCT00005095 - Recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00006230 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
- Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00066729 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; ...
- Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00006942 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003345 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; ...
- Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00021034 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00052468 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00081276 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
- Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00058435 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; ...
- Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003532 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; ...
- Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00031954 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Hormone Therapy With LY353381 Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003670 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
- Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00003998 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
- A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
ClinicalTrials.gov Identifier: NCT00421889 - Recruiting
Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer
- Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003214 - Active, not recruiting
Ovarian Cancer
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00004221 - Active, not recruiting
ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
- Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00030706 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Quality-of-Life Assessment in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003772 - Active, not recruiting
recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
- Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00004064 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00003425 - Active, not recruiting
Leukemia; Bone Cancer; ovarian sarcoma; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma
- Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
ovarian epithelial cancer
- Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00004876 - Recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
ClinicalTrials.gov Identifier: NCT00003120 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
- Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00053833 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; ...
- Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003450 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
- Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
- A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00096993 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00022659 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00563836 - Recruiting
Ovarian Cancer; Epithelial Ovarian Cancer
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003378 - Active, not recruiting
peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00036751 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Second-Line Treatment for Patients with Platinum-Sensitive Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00090610 - Recruiting
Ovarian Cancer
- Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00010179 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ...
- Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00155896 - Recruiting
Ovarian Cancer
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00011986 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy in Treating Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00019045 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00026091 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00006036 - Active, not recruiting
Lung Cancer; lip and oral cavity cancer; Head and Neck Cancer; ovarian sarcoma; ovarian epithelial cancer; Oropharyngeal Cancer
- CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
ovarian epithelial cancer
- Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00501644 - Active, not recruiting
Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
- Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
ClinicalTrials.gov Identifier: NCT00017134 - Active, not recruiting
ovarian epithelial cancer
- A Study to Evaluate the effect of HER2 Activation on rhuMAb 2C4 (pertuzumab) in Subjects with Advanced Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00058552 - Active, not recruiting
Ovarian Cancer
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003136 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003892 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer
- CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00045682 - Active, not recruiting
peritoneal cavity cancer; recurrent ovarian epithelial cancer
- Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients
ClinicalTrials.gov Identifier: NCT00002540 - Active, not recruiting
screening for prostate cancer; ovarian germ cell tumor; Small Cell Lung Cancer; ovarian epithelial cancer; screening for ovarian cancer; ...
- Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
ClinicalTrials.gov Identifier: NCT00337233 - Active, not recruiting
Breast Cancer; Fatigue; Ovarian Cancer; Psychosocial Effects/Treatment
- Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00098878 - Recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00382811 - Recruiting
Fallopian Tube Cancer; Peritoneal Neoplasms; Ovarian Cancer
- A Study Comparing the Combination of Doxil and Yondelis, to Doxil Alone for Subjects with Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00113607 - Active, not recruiting
Ovarian Cancer
- PXD101 in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
ClinicalTrials.gov Identifier: NCT00301756 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00006454 - Active, not recruiting
stage II ovarian epithelial cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00004083 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
- Biological Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
- Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00002894 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
ClinicalTrials.gov Identifier: NCT00032162 - Active, not recruiting
Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; uterine sarcoma; ovarian sarcoma; ovarian carcinosarcoma
- Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00075543 - Active, not recruiting
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00383279 - Active, not recruiting
Cervical Cancer; Ovarian Cancer; Sarcoma
- Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00400348 - Active, not recruiting
Ovarian Cancer
- MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00401674 - Active, not recruiting
Ovarian Cancer
- Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00428766 - Active, not recruiting
Epithelial Ovarian Cancer
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
ClinicalTrials.gov Identifier: NCT00377429 - Active, not recruiting
Ovarian Cancer
- Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00003385 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00461786 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00045214 - Recruiting
Breast Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2); Ovarian Cancer
- Taxol Carboplatin and Erythropoetin
ClinicalTrials.gov Identifier: NCT00158379 - Active, not recruiting
Ovarian Cancer
- Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00170573 - Active, not recruiting
Ovarian Cancer
- Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003449 - Active, not recruiting
recurrent ovarian epithelial cancer
- Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00023712 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
ClinicalTrials.gov Identifier: NCT00189553 - Active, not recruiting
Ovarian Cancer; Fallopian Tube Cancer
- Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
ClinicalTrials.gov Identifier: NCT00003634 - Active, not recruiting
Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life; peritoneal cavity cancer
Resources
- A New Test for Ovarian Cancer (Cleveland Clinic)
- ACOG's Physician Directory (American College of Obstetricians and Gynecologists)
email this page
print this page
bookmark this page
feedback on this page
